zilurgisertib,ruxolitinib
novartis,incyte
['zilurgisertib', 'mpnsm', 'rux,(-crux),(-trux)', 'rux,(-crux),(-trux),(-deruxtecan)', '#mpn']
congress|#asco23| showcased the phase 1/2 study results of alk-2 inhibitor zilurgisertib alone or with rux in pts with anemia due to mf. it was well tolerated with no dlts &amp; mostly grade 1/2 teas and reduced hepecidin levels across all doses
#mpnsm 
Lifting levels of knowledge in myeloproliferative neoplasms (MPN). A global online platform providing latest treatment options and medical information #mpnsm